Xeris Pharmaceuticals | XERS - Net Income


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Xeris Pharmaceuticals

Xeris Pharmaceuticals Inc reported $-12930000 in Net Income for its fiscal quarter ending in December of 2022.


Net Income Change
Eli Lilly LLY:US USD 1.34B 592.8M
Endo International ENDP:US USD -3279000 240.26M
Horizon Pharma HZNP:US USD 54.68M 65.72M
Nektar Therapeutics NKTR:US USD -137018000 77.33M
Pacira PCRX:US USD -19536000 9.43M
Perrigo PRGO:US USD -3000000 20.7M
Supernus Pharmaceuticals SUPN:US USD 16.95M 8.53M